Article | Published:

Fragmented Care is Prevalent among Inflammatory Bowel Disease Readmissions and is Associated with Worse Outcomes

The American Journal of Gastroenterology (2018) | Download Citation

Subjects

Abstract

Background

Inflammatory bowel disease (IBD) is a complex chronic disease that often requires a multispeciality approach; thus, IBD patients are prone to care fragmentation. We aim to determine the prevalence of fragmentation among hospitalized IBD patients and identify associated predictors and visit-level outcomes.

Methods

The State Inpatient Databases for New York and Florida were used to identify 90-day readmissions among IBD inpatients from 2009 to 2013. The prevalence of fragmentation, defined as a readmission to a non-index hospital, was reported. Characteristics associated with fragmented care were identified using multivariable logistic regression. Multivariable models were utilized to determine the association between fragmentation and outcomes (in-hospital mortality, readmission length of stay, and inpatient colonoscopy).

Results

Among IBD inpatients, 25,241 and 29,033 90-day readmission visits were identified, in New York and Florida, respectively. The prevalence of fragmentation was 26.4% in New York and 32.5% in Florida. Younger age, a non-emergent admission type, public payer or uninsured status, mood disorder, and substance abuse were associated with fragmented care, while female gender and a primary diagnosis of an IBD-related complication had an inverse association. Fragmented inpatient care is associated with a higher likelihood of in-hospital death, higher rates of inpatient colonoscopy, and a longer readmission length of stay.

Conclusion

Over one in four IBD inpatient readmissions are fragmented. Disparities and differences in fragmentation exist and contribute to poor patient outcomes. Additional efforts targeting fragmentation should be made to better coordinate IBD management, reduce healthcare gaps, and promote high-value care.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Regueiro M, Click B, Holder D et al . Constructing an inflammatory bowel disease patient-centered medical home. Clin Gastroenterol Hepatol. 2017;15:1148–53.

  2. 2.

    Regueiro M. Medical homes for patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2017;13:375–7.

  3. 3.

    Cars T, Wettermark B, Löfberg R et al. Healthcare utilisation and drug treatment in a large cohort of patients with inflammatory bowel disease. J Crohns Colitis. 2016;10:556–65.

  4. 4.

    Park MD, Bhattacharya J, Park K. Differences in healthcare expenditures for inflammatory bowel disease by insurance status, income, and clinical care setting. PeerJ. 2014;2:e587.

  5. 5.

    Wasfy JH, Zigler CM, Choirat C et al. Readmission rates after passage of the hospital readmissions reduction program: a pre-post analysis. Ann Intern Med. 2017;166:324–31.

  6. 6.

    Brooke BS, Goodney PP, Kraiss LW et al. Readmission destination and risk of mortality after major surgery: an observational cohort study. Lancet. 2015;386:884–95.

  7. 7.

    Schrag D, Xu F, Hanger M et al. Fragmentation of care for frequently hospitalized urban residents. Med Care. 2006;44:560–7.

  8. 8.

    Vest JR, Kern LM, Silver MD et al. The potential for community-based health information exchange systems to reduce hospital readmissions. J Am Med Inform Assoc. 2015;22:435–42.

  9. 9.

    Frandsen BR, Joynt KE, Rebitzer JB et al. Care fragmentation, quality, and costs among chronically ill patients. Am J Manag Care. 2015;21:355–62.

  10. 10.

    Enthoven AC. Integrated delivery systems: the cure for fragmentation. Am J Manag Care. 2009;15:S284–90.

  11. 11.

    Stange KC. The problem of fragmentation and the need for integrative solutions. Ann Fam Med. 2009;7:100–3.

  12. 12.

    Kern LM, Grinspan Z, Shapiro JS et al. Patients’ use of multiple hospitals in a major us city: implications for population management. Popul Health Manag. 2017;20:99–102.

  13. 13.

    Kothari AN, Loy VM, Brownlee SA, et al. Adverse effect of post-discharge care fragmentation on outcomes after readmissions after liver transplantation. J Am Coll Surg. 2017;225:62–7.

  14. 14.

    Zafar SN, Shah AA, Channa H, Raoof M, Wilson L, Wasif N. Comparison of rates and outcomes of readmission to index vs nonindex hospitals after major cancer surgery. JAMA Surg. 2018;153:719–27.

  15. 15.

    Tsai TC, Orav EJ, Jha AK. Care fragmentation in the postdischarge period: surgical readmissions, distance of travel, and postoperative mortality. JAMA Surg. 2015;150:59–64.

  16. 16.

    HCUP Databases. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD. https://www.hcup-us.ahrq.gov/sidoverview.jsp. Accessed July 2018.

  17. 17.

    HCUP Supplemental Files for Revisit Analyses. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD. https://www.hcupus.ahrq.gov/toolssoftware/revisit/revisit.jsp. Accessed August 2018.

  18. 18.

    Barnes EL, Kochar B, Long MD, et al. Modifiable risk factors for hospital readmission among patients with inflammatory bowel disease in a nationwide database. Inflamm Bowel Dis. 2017;23:875–81.

  19. 19.

    Ananthakrishnan AN, McGinley EL, Binion DG. Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume. Am J Gastroenterol. 2008;103:2789–98.

  20. 20.

    Rumalla K, Smith KA, Arnold PM. National Rates, causes, risk factors, and outcomes associated with 30-day and 90-day readmissions following degenerative posterior cervical spine surgery utilizing the nationwide readmissions database. Neurosurgery. 2017;81:740–51.

  21. 21.

    Stimson CJ, Chang SS, Barocas DA, et al. Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J Urol. 2010;184:1296–300.

  22. 22.

    Dharmarajan K, Hsieh AF, Kulkarni VT, et al. Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study. BMJ. 2015;350:h411.

  23. 23.

    HCUP Central Distributor SID Description of Data Elements - All States. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov/db/vars/siddistnote.jsp?var=hospid. Accessed August 2008.

  24. 24.

    Poojary P, Saha A, Chauhan K. et al.Predictors of hospital readmissions for ulcerative colitis in the united states: a national database study.Inflamm Bowel Dis. 2017;23:347–56.

  25. 25.

    HCUP CCS. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD. https://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed March 2017.

  26. 26.

    Elixhauser A, Steiner C, Harris DR et al. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.

  27. 27.

    Burke RE, Jones CD, Hosokawa P et al. Influence of nonindex hospital readmission on length of stay and mortality. Med Care. 2018;56:85–90.

  28. 28.

    Wasfy, JH, Dominici D, Wang Y, Yeh RW. Proportion of readmissions to non-index hospitals is associated with all-cause risk-adjusted readmission rate for medicare patients with AMI and CHF. 2015; A371–A371.

  29. 29.

    Cloyd JM, Huang L, Ma Y. et al. Predictors of readmission to non-index hospitals after colorectal surgery. Am J Surg. 2017;213:18–23.

  30. 30.

    Zheng C, Habermann EB, Shara NM, et al. Fragmentation of care after surgical discharge: non-index readmission after major cancer surgery. J Am Coll Surg. 2016;222:780–9.e2.

  31. 31.

    Jiang HJ, Boutwell AE, Maxwell J et al.Understanding patient, provider, and system factors related to medicaid readmissions. Jt Comm J Qual Patient Saf. 2016;42:115–21.

  32. 32.

    Compton-Phillips AM, Seth N. Care redesign survey: it’s time to treat physical and mental health with equal intent. NEJM Catalyst. 2018;1–16.

  33. 33.

    Blixen CE, Kanuch S, Perzynski AT et al.Barriers to self-management of serious mental illness and diabetes. Am J Health Behav. 2016;40:194–204.

  34. 34.

    Agha L, Frandsen B, and Rebitzer JB. Causes and consequences of fragmented care delivery: theory, evidence, and public policy. no. w23078. National Bureau of Economic Research, 2017.

  35. 35.

    Romano MJ, Segal JB, Pollack CE. The association between continuity of care and the overuse of medical procedures. JAMA Intern Med. 2015;175:1148–54.

  36. 36.

    Ananthakrishnan AN, McGinley EL, Binion DG et al. A nationwide analysis of changes in severity and outcomes of inflammatory bowel disease hospitalizations. J Gastrointest Surg. 2011;15:267–76.

  37. 37.

    Ramsey M, Krishna SG, Stanich PP, et al. Inflammatory bowel disease adversely impacts colorectal cancer surgery short-term outcomes and health-care resource utilization. Clin Transl Gastroenterol. 2017;8:e127.

  38. 38.

    Table 1. Annual Estimates of the Resident Population for the United States, Regions, States, and Puerto Rico: April 1, 2010 to July 1, 2017 (NST-EST2017-01). U.S. Census Bureau, Population Division. https://www.census.gov/quickfacts/fact/table/US/PST045217. Release Date: December 2017. Retrieved February 11, 2018.

  39. 39.

    Dulai PS, Singh S, Ohno-Machado L, Sandborn WJ. Population health management for inflammatory bowel disease. Gastroenterology. 2017;154:37–45.

Download references

Author information

Affiliations

  1. Division of Gastroenterology & Hepatology, University of Michigan, Ann Arbor, MI, 48109, USA

    • Shirley Cohen-Mekelburg MD, MS
    • , Akbar K. Waljee MD, MSc
    •  & Sameer Saini MD, MSc
  2. Division of Gastroenterology & Hepatology, New York Presbyterian Weill Cornell Medicine, New York, NY, 10021, USA

    • Russell Rosenblatt MD, MS
    • , Nicole Shen MD
    • , Brett Fortune MD, MSc
    • , Ellen Scherl MD
    •  & Robert Burakoff MD, MPH
  3. Department of Medicine, New York Presbyterian Weill Cornell Medicine, New York, NY, 10021, USA

    • Stephanie Gold MD
  4. Department of Healthcare Policy & Research, New York Presbyterian Weill Cornell Medicine, New York, NY, 10021, USA

    • Mark Unruh PhD
  5. VA Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI, 48105, USA

    • Akbar K. Waljee MD, MSc
    •  & Sameer Saini MD, MSc
  6. Michigan Integrated Center for Health Analytics and Medical Prediction (MiCHAMP), Ann Arbor, MI, 48109, USA

    • Akbar K. Waljee MD, MSc

Authors

  1. Search for Shirley Cohen-Mekelburg MD, MS in:

  2. Search for Russell Rosenblatt MD, MS in:

  3. Search for Stephanie Gold MD in:

  4. Search for Nicole Shen MD in:

  5. Search for Brett Fortune MD, MSc in:

  6. Search for Akbar K. Waljee MD, MSc in:

  7. Search for Sameer Saini MD, MSc in:

  8. Search for Ellen Scherl MD in:

  9. Search for Robert Burakoff MD, MPH in:

  10. Search for Mark Unruh PhD in:

Guarantor of the article

Shirley Cohen-Mekelburg, MD, MS.

Specific author contributions

Shirley Cohen-Mekelburg, Russell Rosenblatt, Stephanie Gold, and Mark Unruh were involved in the study concept and design, data management, statistical analysis and interpretation of data, drafting of manuscript, and critical revisions. In addition, Shirley Cohen-Mekelburg and Mark Unruh were involved in study supervision. Brett Fortune, Ellen Scherl, Robert Burakoff, Akbar K. Waljee, and Sameer Saini were involved in interpretation of data and critical revisions. All authors approved the final version of the article, including the authorship list

Financial support

None.

Potential competing interests

ES has received grant/research support from Abbott Laboratories (AbbVie), AstraZeneca, Janssen Research & Development, and Pfizer, and serves as a consultant to AbbVie, Janssen Pharmaceutical, and Takeda Pharmaceuticals. The remaining authors declare that they have no conflict of interest.

Corresponding author

Correspondence to Shirley Cohen-Mekelburg MD, MS.

Appendix

Appendix

Table 3 and 4

Table 3 List of the International Classification of Diseases, Ninth revision, Clinical modification (ICD-9-CM) diagnostic and procedure codes
Table 4 Factors associated with fragmentation in care among all cause IBD-related 30-day readmissions

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/s41395-018-0417-9